These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 26760086)

  • 1. Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.
    Compton WM; Jones CM; Baldwin GT
    N Engl J Med; 2016 Jan; 374(2):154-63. PubMed ID: 26760086
    [No Abstract]   [Full Text] [Related]  

  • 2. Analyzing the Relationship between Nonmedical Prescription-Opioid use and Heroin USE.
    Ruan X; Wyche MQ; Kaye AD
    J Opioid Manag; 2016; 12(1):11-4. PubMed ID: 26943818
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonmedical Prescription-Opioid Use and Heroin Use.
    Cicero TJ; Ellis MS
    N Engl J Med; 2016 Mar; 374(13):1295-6. PubMed ID: 27028931
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonmedical Prescription-Opioid Use and Heroin Use.
    Compton WM; Jones CM; Baldwin GT
    N Engl J Med; 2016 Mar; 374(13):1296. PubMed ID: 27028930
    [No Abstract]   [Full Text] [Related]  

  • 5. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons.
    Jauncey M; Livingston M; Salmon AM; Dietze P
    Int J Drug Policy; 2018 Mar; 53():17-22. PubMed ID: 29268238
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.
    Martins SS; Segura LE; Santaella-Tenorio J; Perlmutter A; Fenton MC; Cerdá M; Keyes KM; Ghandour LA; Storr CL; Hasin DS
    Addict Behav; 2017 Feb; 65():236-241. PubMed ID: 27614657
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender differences in trends for heroin use and nonmedical prescription opioid use, 2007-2014.
    Marsh JC; Park K; Lin YA; Bersamira C
    J Subst Abuse Treat; 2018 Apr; 87():79-85. PubMed ID: 29433788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose.
    Guarino H; Mateu-Gelabert P; Teubl J; Goodbody E
    Addict Behav; 2018 Nov; 86():118-123. PubMed ID: 29747875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmedical Opioid Use in Relation to Recency of Heroin Use in a Nationally Representative Sample of Adults in the United States.
    Palamar JJ; Shearston JA
    J Psychoactive Drugs; 2018; 50(2):159-166. PubMed ID: 28895798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmedical Use of Prescription Opioids, Heroin Use, Injection Drug Use, and Overdose Mortality in U.S. Adolescents.
    Bohm MK; Clayton HB
    J Stud Alcohol Drugs; 2020 Jul; 81(4):484-488. PubMed ID: 32800085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of prescription fentanyl misuse in the United States.
    Schepis TS; McCabe VV; Boyd CJ; McCabe SE
    Addict Behav; 2019 Sep; 96():89-93. PubMed ID: 31063940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing opioid drug misuse in America.
    Lancet; 2015 Jul; 386(9990):220. PubMed ID: 26194507
    [No Abstract]   [Full Text] [Related]  

  • 14. Underlying Factors in Drug Overdose Deaths.
    Dowell D; Noonan RK; Houry D
    JAMA; 2017 Dec; 318(23):2295-2296. PubMed ID: 29049472
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in non-medical prescription opioids and heroin co-use among adults, 2003-2014.
    Mital S; Windle M; Cooper HLF; Crawford ND
    Addict Behav; 2018 Nov; 86():17-23. PubMed ID: 29778489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
    Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
    Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths.
    U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):133-9. PubMed ID: 26095483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription painkiller misuse and the perceived risk of harm from using heroin.
    Kapadia SN; Bao Y
    Addict Behav; 2019 Jun; 93():141-145. PubMed ID: 30711666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.
    Unick GJ; Ciccarone D
    Int J Drug Policy; 2017 Aug; 46():112-119. PubMed ID: 28688539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing Prescription Opioid and Heroin Overdose Mortality in the United States, 1999-2014: An Age-Period-Cohort Analysis.
    Huang X; Keyes KM; Li G
    Am J Public Health; 2018 Jan; 108(1):131-136. PubMed ID: 29161066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.